Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07449000 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Losartan for Corneal Fibrosis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This is a prospective, randomized, double-blinded, controlled clinical trial designed to evaluate the efficacy and safety of topical losartan in improving visual acuity, contrast sensitivity and reducing corneal densitometry, corneal aberrations and corneal scarring severity in adult patients with corneal scars of different etiologies. Participants will be randomly assigned to receive either topical losartan 0.8 mg/mL or placebo eyedrops 6 times per day for six months.
Trial Details
NCT Number NCT07449000
Lead Sponsor Universidad Autonoma de Nuevo Leon
Conditions
(from sponsor)		 Corneal Scarring Fibrosis
Related terms Corneal Injuries, Corneal Opacity
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov